For the 2026 Neuro-Urology Guidelines, new and relevant evidence was identified, collated and appraised through a structured assessment of the literature for all sections of the Guidelines. Key changes include:
- Updates throughout Table 1 and the inclusion of data for Inflammatory radiculitis and updates in Table 4 regarding current personal history.
- A new paragraph in section 3.3.3 on the timing of diagnosis and treatment.
- A new subchapter 3.3.7.c on pelvic neurophysiology tests and inclusion in the summary of evidence.
- Two new recommendations in section 3.4.1 on shared decision-making.
- New additional paragraphs throughout section 3.4.2.b on neuro-urological rehabilitation and section 3.4.2.c on Drug treatment as well as additions to the summary of evidence and recommendations.
- New additional paragraphs throughout section 3.4.2.e on Minimally invasive treatment including new summary of evidence and recommendations on catheterisation.
- Update on the summary of evidence and recommendations in section 3.4.2.e.6 on Botulinum toxin A injections.
- Various updates in section 3.5.4, in the summary of evidence and recommendations for the treatment of UTI.
- Update in section 3.7 on Follow-up including new summary of evidence and recommendations.
- New sub section 3.8.1 on the patient’s perspective on lower urinary tract diagnosis and management in neurological patients.